WST / 5 High-Quality Stocks Outperforming the S&P 500

West Pharmaceutical Services, Inc. (NYSE:WST ) Q3 2023 Earnings Conference Call October 26, 2023 9:00 AM ET Company Participants Quintin Lai - Vice Pr more_horizontal

West Pharmaceutical Services (WST) came out with quarterly earnings of $2.16 per share, beating the Zacks Consensus Estimate of $1.86 per share. This more_horizontal

Medical equipment maker West Pharmaceutical Services on Thursday raised its 2023 adjusted profit forecast for a third time, benefiting from a stronger more_horizontal

West Pharmaceutical's (WST) third-quarter 2023 results are likely to reflect strength in the Proprietary Products business. However, unfavorable curre more_horizontal

West Pharmaceutical Services, Inc. has experienced a 60% gain in its stock price so far in 2023 but has hit some recent technical headwinds. Insiders more_horizontal

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist. more_horizontal

Although these companies are from different sectors, we compare them because they have a similar market capitalization of around $30 billion. more_horizontal

West Pharmaceutical's (WST) strength in its proprietary products segment raises optimism about the stock. more_horizontal